2017-09-19T14:01:47-05:00 2016-12-31 Grant Thornton LLP 100 E Wisconsin Ave Milwaukee WI 53202 990 2016-01-01 381550001 Michigan Blood % CHARLEEN MELLO MICH 6167742300 PO Box 1704 Grand Rapids MI 495011704 JAMES WILSON President/CEO 4142898200 2017-09-14 true Michelle L Weber P00556798 4142898200 38.84.128.189 39529020172625000001 2017-09-19 P 7679050E6FFD33370EE8F5FB1864EBFE89AF94B5 DBB5A1BB300CE7347E9A562499B28AD7099757F8 2016 2021-01-29 14:40:06Z James Wilson PO Box 1704 Grand Rapids MI 495011704 58023668 false X www.miblood.org X 1955 MI HELPING PEOPLE MAKE A LIFESAVING DIFFERENCE THROUGH BLOOD PRODUCTS AND SERVICE EXCELLENCE 6 5 589 494 0 413021 490987 46720288 55986833 456307 331865 -78 -7710 47589538 56801975 36000 0 0 0 21286696 22350932 0 0 0 26298185 34715057 47620881 57065989 -31343 -264014 34842679 35404153 6284042 6672254 28558637 28731899 X THE PURPOSE OF MICHIGAN BLOOD IS TO PROVIDE A SAFE AND ADEQUATE BLOOD SUPPLY AND BLOOD-RELATED SERVICES FOR THE COMMUNITIES SERVED BY HOSPITAL PARTNERS THROUGHOUT THE STATE. MICHIGAN BLOOD IS THE SOLE PROVIDER OF BLOOD FOR 60 HOSPITAL FACILITIES. THESE HOSPITALS INCLUDE MAJOR MEDICAL CENTERS (SECONDARY- AND TERTIARY-CARE TEACHING FACILITIES) SERVING POPULATIONS TOTALING MORE THAN 2.5 MILLION PEOPLE. MICHIGAN BLOOD SUPPORTS ANOTHER DOZEN HOSPITALS THROUGH SUPPLEMENTAL CONTRACTS. THROUGH DONOR CENTERS AND BLOOD DRIVES IN NORTHWEST, EAST-CENTRAL, WEST, SOUTHWEST AND SOUTHEAST MICHIGAN, MICHIGAN BLOOD RECRUITS AND COLLECTS BLOOD FROM VOLUNTEER DONORS TO ACHIEVE ITS LIFESAVING MISSION. ANNUALLY, MICHIGAN BLOOD COLLECTS APPROXIMATELY 128,000 UNITS OF BLOOD FROM VOLUNTEER BLOOD DONORS AND DISTRIBUTES 298,000 BLOOD COMPONENTS. false false 49643781 0 55986833 FOR OVER 60 YEARS, MICHIGAN BLOOD HAS PROUDLY SERVED MICHIGAN HOSPITALS AS AN INDEPENDENT, COMMUNITY-BASED, NONPROFIT BLOOD CENTER. IN ADDITION TO BLOOD DONATION, MICHIGAN BLOOD ADMINISTERS A VARIETY OF KEY PROGRAMS AND SPECIALTY SERVICES THAT FURTHER OUR LIFESAVING MISSION. THESE SERVICES INCLUDE A NATIONALLY RECOGNIZED CENTER FOR THE NATIONAL MARROW DONOR PROGRAM, ONE OF ONLY 25 PUBLIC CORD BLOOD BANKS IN AMERICA, AND WE WORK ALONGSIDE LOCAL HOSPITALS TO DELIVER A NUMBER OF MEDICAL SERVICES AND THERAPEUTIC PROCEDURES. MICHIGAN BLOOD IS ALSO AFFILIATED WITH VERSITI, AN ORGANIZATION WHOSE MEMBERS SHARE RESOURCES AND EXPERTISE TO IMPROVE PATIENT OUTCOMES, AS WELL AS CONDUCT LEADING EDGE MEDICAL RESEARCH AND PROVIDE NATIONWIDE DIAGNOSTIC LAB SERVICES. TO LEARN MORE ABOUT THE PROGRAM SERVICES MICHIGAN BLOOD PROVIDES PLEASE SEE DETAILED DESCRIPTIONS BELOW: BLOOD DONATION: VOLUNTEER BLOOD DONORS GIVE BLOOD AT EIGHT PERMANENT DONOR CENTERS THROUGHOUT MICHIGAN AND AT BLOOD DRIVES HOSTED BY COMMUNITY ORGANIZATIONS AND BUSINESSES. EACH MICHIGAN BLOOD region ALSO OPERATES A SELF-CONTAINED BLOOD CENTER ON WHEELS. THESE "BLOOD BUSES" HELP EXPAND OUR REACH TO SMALL COMMUNITIES AND URBAN AREAS WHERE SPACE IS AT A PREMIUM. SEE WWW.MIBLOOD.ORG FOR A COMPREHENSIVE LIST OF DONATION LOCATIONS. APHERESIS: SPECIAL EQUIPMENT MAKES IT POSSIBLE TO COLLECT ONE OR MORE SPECIFIC BLOOD COMPONENTS FROM A DONOR, WHILE RETURNING THE REMAINING COMPONENTS BACK TO THE DONOR. APHERESIS DONATIONS ALLOW A GREATER QUANTITY OF ONE COMPONENT TO BE DRAWN VERSUS A STANDARD WHOLE BLOOD DONATION. THESE LARGER COMPONENT-SPECIFIC DONATIONS HELP REDUCE THE NUMBER OF DONORS A PATIENT IS EXPOSED TO, WHICH IS PREFERRED BY MOST PHYSICIANS. ALSO, PATIENTS WITH DISEASES SUCH AS TTP, KIDNEY REJECTIONS, MYASTHENIA GRAVIS, SICKLE CELL DISEASE, OR LEUKEMIA CAN BE TREATED BY THE REMOVAL OF ONE OR MORE BLOOD COMPONENTS USING THERAPEUTIC APHERESIS TECHNOLOGY. MICHIGAN BLOOD STAFF AND EQUIPMENT TRAVEL TO GRAND RAPIDS AREA HOSPITALS TO PERFORM ROUGHLY 2,000 PROCEDURE'S ANNUALLY. MARROW/STEM CELL PROGRAM: IN THE PAST 20 YEARS, MICHIGAN BLOOD/VERSITI NMDP SERVICES HAS ESTABLISHED ONE OF THE PREMIER RECRUITMENT DONOR CENTER RECORDS IN THE UNITED STATES. MICHIGAN BLOOD/VERSITI ADDED MORE THAN 130,000 INDIVIDUALS WITH ADVANCED TISSUE TYPING TO THE REGISTRY OF POTENTIAL STEM CELL DONORS MAINTAINED BY THE BE THE MATCH REGISTRY (NATIONAL MARROW DONOR PROGRAM). IN 2010, THE DONOR CENTER RECEIVED THE DONOR MANAGEMENT RECOGNITION AWARD, A LIFETIME ACHIEVEMENT AWARD. NMDP SERVICES ALSO PROVIDES SUPPORT SERVICES FOR PATIENTS AND FAMILIES SEEKING COMPATIBLE STEM CELL DONORS. STEM CELL TRANSPLANTS REMAIN THE PRIMARY SOURCE OF HOPE FOR PATIENTS WITH CERTAIN KINDS OF LIFE-THREATENING DISEASES. MICHIGAN BLOOD HAS HELPED FACILITATE LIFESAVING STEM CELL TRANSPLANTS FOR NEARLY 700 PEOPLE AROUND THE WORLD. CORD BLOOD BANK/STEM CELL PROCESSING LABORATORY: MICHIGAN BLOOD CORD BLOOD BANK, THE FIRST OF ITS KIND IN MICHIGAN, HAS COLLECTED AND STORED BLOOD FROM MORE THAN 3,789 UMBILICAL CORDS. CORD BLOOD IS RICH IN STEM CELLS AND CORD BLOOD TRANSPLANTATION IS FINDING APPLICATION IN CHILDREN AND ADULTS AROUND THE GLOBE SUFFERING FROM CERTAIN LIFE-THREATENING DISEASES. LOCAL AVAILABILITY OF STEM CELL COLLECTION, PROCESSING, STORAGE, AND PRE-TRANSPLANT PREPARATION SUPPORTS THE LOCAL TRANSPLANT PROGRAM'S ABILITY TO OFFER ADVANCED MEDICAL CARE. IT ALSO OFFERS INCREASED CONVENIENCE AND REDUCED STRESS FOR PATIENTS AND FAMILIES WHO PREVIOUSLY HAD TO TRAVEL LONG DISTANCES FOR TRANSPLANT SERVICES. Cellular therapy: As part of ever-changing medical landscape, Michigan blood supports personalized cellular therapy treatments used in a number of cancers and other life-threatening diseases. For instance, Michigan blood collects cells from prostate cancer patients to be used in the preparation of personalized treatments. Other applications are routinely being researched and trialed in hopes of gaining FDA approval. MICHIGAN BLOOD ALSO COLLECTS PATIENT WHITE CELLS AND PROCESSES THEM WITH UV LIGHT TO HELP TREAT GRAFT VS. HOST DISEASE AND CUTANEOUS T-CELL LYMPHOMA. DNA/HLA laboratory: This laboratory uses special techniques to conduct tissue typing at the genetic code level to evaluate donor-patient compatibility before transplantation. Local availability of these services helps doctors respond faster to urgent patient needs caused by aggressive diseases. Patients with transfusion/pregnancy-related sensitivities also benefit from the services of the DNA/HLA laboratory which helps physicians diagnose, treat and find appropriate blood products. The DNA/HLA laboratory also types apheresis donors to identify life-saving matches for patients needing component transfusion. Reference laboratory: Patients with complex transfusion-related sensitivities benefit from the services of the red cell reference laboratory, which provides information that helps physicians diagnose and treat complicated cases and find rare blood types for transfusion. These patients often are critically ill and may suffer serious complications (including death) without special laboratory services to help their doctors assess the risks of transfusion reactions and donor/recipient incompatibilities. Volunteerism: Michigan blood offers a wide variety of opportunities for community members interested in volunteering their time to help their community and support Michigan blood's lifesaving mission. 49643781 true true false false false false false false false true true true false false false true false true false false false false false false true false false false false true false false false false false false false false true false false false false true false false false true 27 1 true 589 true false false false false false true true false false false false X 6 5 false false true false true true true true true false false true true true true true true true true false MI X CHARLEEN MELLO 6162338613 1036 FULLER NE Grand Rapids MI 49503 X James Wilson COO-thru 9/16;pres-as of 10/16 55.0 0.0 X X 223596 0 18481 Paul D Smith Jr Secretary/Treasurer 1.0 0.0 X X 0 0 0 Chuck Downey Chair 1.0 0.0 X X 0 0 0 Mitchell G Watt Vice Chair 1.0 3.0 X X 0 0 0 Jack O'Donnell MD Director 1.0 0.0 X 0 0 0 John J Perras Director 1.0 3.0 X 0 0 0 Bill Rietscha President/CEO - thru 9/2016 54.0 1.0 X X 302991 0 22839 Leeann Wietekamp VP of Quality & Medical Svcs 55.0 0.0 X 285468 0 21925 Anthony Watkins Sr VP & CFO 5.0 50.0 X 40207 361869 44832 Margaret McElligott VP Quality Services 7.0 48.0 X 30053 210373 42955 Sandi Lemons VP Human Resource Services 9.0 46.0 X 42629 227856 38875 Lynne Briggs VP Information Svcs & CIO 6.0 49.0 X 27644 248799 42636 Maureen Kwiecinski Asst Corporate Secretary 9.0 46.0 X 62396 311978 30879 Robert Eluskie Director of Info Technology 55.0 0.0 X 113534 0 14685 M Elizabeth Atkinson Cole Associate Medical Director 55.0 0.0 X 106967 0 8799 Cindy Raven VP of Community Relations 55.0 0.0 X 106684 0 14343 Mary Catherine Dawson Director of Donor Recruitment 55.0 0.0 X 104545 0 11125 Jennifer Lee Bird Director of Reg. Compliance/QA 55.0 0.0 X 102006 0 14223 1548720 1360875 326597 16 false true false 0 13699 6790 384500 85998 66610 490987 BLOOD PRODUCTS/TESTING 621500 49710474 49710474 SPECIAL SERVICES 621500 6271822 6271822 MISCELLANEOUS REVENUE 621500 4537 4537 55986833 232168 232168 0 0 0 0 0 1226091 69905 1085470 110829 140621 -40924 99697 99697 9992 13699 16184 -6192 -6192 7692 9210 -1518 -1518 0 0 0 0 56801975 55986833 324155 0 0 0 0 1103890 1103890 0 16708074 14515252 2192822 379376 360070 19306 2922218 2529311 392907 1237374 1054489 182885 0 21644 21644 92884 92884 0 0 37808 37808 5907706 6124704 -216998 262288 36 262252 433733 327360 106373 242168 1680 240488 0 2395598 906629 1488969 774839 695162 79677 0 315070 229112 85958 62479 62479 0 1683742 683736 1000006 194800 194800 IMPORTED BLOOD COMPONENTS 15543678 15543678 MEDICAL LAB SUPPLIES 6167834 6208117 -40283 DONOR RECRUITMENT 356624 356061 563 DUES AND MEMBERSHIPS 74033 7011 67022 148129 101373 46756 57065989 49643781 7422208 0 2987192 3131486 0 0 30050 271302 4182559 5851195 0 0 0 0 0 0 2290197 1398929 650877 669888 30869314 18668443 13518280 12200871 0 0 10828666 11539525 0 0 0 0 354858 340957 34842679 35404153 4060130 5035908 0 0 0 0 0 0 0 0 0 0 2223912 1636346 0 0 0 0 6284042 6672254 X 28464544 28601911 83943 119838 10150 10150 28558637 28731899 34842679 35404153 -264014 437276 X false true X true false X 97964 98507 2206994 413021 490987 3307473 40481179 21965633 41106448 46720288 55986833 206260381 0 0 0 40579143 22064140 43313442 47133309 56477820 209567854 0 22220741 11144406 20402773 20475467 27650583 101893970 22220741 11144406 20402773 20475467 27650583 101893970 107673884 319140 268012 452545 400847 232168 1672712 0 319140 268012 452545 400847 232168 1672712 0 20595 10882 18881 13936 17684 81978 40918878 22343034 43784868 47548092 56727672 211322544 0.50952 0.49905 0.00792 0.00876 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 72401518 793676 7045041 3800429 76439806 1.00000 false true true 2546071 2546071 14217108 8410069 5807039 936679 443697 492982 10532672 7752957 2779715 2636784 2061720 575064 12200871 MUTUAL FUNDS 11539525 F 11539525 0 0 X 57305569 437276 25394 462670 56842899 -40924 -40924 56801975 57132307 25394 25394 57106913 -40924 -40924 57065989 Part V Endowment During 2016, the filing organization was added as a beneficiary of the BloodCenter Research Foundation endowment as a supported organization. Part X Income Taxes Versiti, BloodCenter, Heartland, Michigan, Indiana and the Foundation have all received tax determination letters confirming that the organizations qualify as tax-exempt organizations under section 501(c)(3) of the Internal Revenue Code (IRC). The Organization follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and measurement. This guidance provides that the tax effects from an uncertain tax position can only be recognized in the financial statements if the position is more likely than not to be sustained if the position were to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. Versiti, BloodCenter, Heartland, Michigan, Indiana and the Foundation are exempt from federal income tax under IRC section 501(c)(3), though they are subject to tax on income unrelated to their exempt purposes, unless that income is otherwise excluded by the IRC. The Organization has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. Michigan has not historically filed any unrelated business income tax returns; therefore, tax years remain open for years in which an income tax return has not been filed. The Organization has determined that there are no material uncertain tax positions that require recognition or disclosure in the consolidated financial statements. The Organization recognizes, if necessary, interest and penalties related to unrecognized tax benefits in the provision for income taxes. There were no interest or penalties related to income taxes that have been accrued or recognized as of and for the years ended December 31, 2016 and 2015. Part XI, Line 2D Other Changes to Revenue Fundraising Expenses Reported with Revenue $16,184 Gaming Expenses Reported with Revenue 9,210 ------- Total $25,394 Part XI, Line 4B Other Changes to Revenue Loss on Sale of Fixed Assets Reported with Revenue $(40,924) Part XII, Line 2D Other Changes to Expenses Fundraising Expenses Reported with Revenue $16,184 Gaming Expenses Reported with Revenue 9,210 ------- Total 25,394 Part XII, Line 4B Other Changes to Expenses Loss on Sale of Fixed Assets Reported with Revenue $(40,924) Golf Outing 23691 13699 9992 116 6630 4210 5228 0 23691 13699 9992 116 6630 4210 5228 16184 -6192 X X X X false false false false false false false true false James Wilson COO-thru 9/16;pres-as of 10/16 189747 0 9500 0 24349 0 8112 0 10369 0 242077 0 0 0 Bill Rietscha President/CEO - thru 9/2016 246002 0 0 0 56989 0 10200 0 12639 0 325830 0 0 0 Leeann Wietekamp VP of Quality & Medical Svcs 245398 0 0 0 40070 0 10200 0 11725 0 307393 0 0 0 Anthony Watkins Sr VP & CFO 35035 315318 4295 38659 877 7892 2237 20135 2246 20214 44690 402218 0 0 Margaret McElligott VP Quality Services 25023 175158 2391 16737 2639 18478 3150 22048 2220 15537 35423 247958 0 0 Sandi Lemons VP Human Resource Services 38983 208374 3510 18759 136 723 2873 15353 3254 17395 48756 260604 0 0 Lynne Briggs VP Information Svcs & CIO 25181 226634 2219 19968 244 2197 2103 18928 2161 19444 31908 287171 0 0 Maureen Kwiecinski Asst Corporate Secretary 53585 267926 5615 28075 3196 15977 4268 21340 879 4392 67543 337710 0 0 Part I, Line 7 Non-Fixed Payments Incentive payout opportunities, based on percentage of base pay rate, are available to certain employees of the filing organization. While levels of the incentive payout opportunity are fixed and determined percentages of base compensation; the incentive payout is subject to the review of accomplishments/objectives and the ultimate determination of incentive compensation is subject to president/CEO and executive committee of the board approval. X Gift Cards 1 57500 FMV X Raffle Items 45 9110 FMV false false false Part VI, Section A, Line 4 Significant Changes to Governing Documents THE FILING ORGANIZATION'S BYLAWS WERE AMENDED ON OCTOBER 1, 2016 TO: - CHANGE VERSITI FROM SOLE CORPORATE MEMBER TO SOLE VOTING MEMBER. - ADD PROVISION FOR INDIVIDUAL NON-VOTING MEMBERS. - CREATE 2 CLASSES OF DIRECTORS: ONE CLASS IS ELECTED BY THE CORPORATE MEMBER ("MEMBER DIRECTORS") AND THE OTHER CLASS IS ELECTED BY THE BOARD OF DIRECTORS ("AT-LARGE DIRECTORS"). THE MEMBER DIRECTORS SHALL HOLD AT ALL TIMES THE MINIMUM NUMBER OF SEATS ON THE BOARD OF DIRECTORS NECESSARY TO CONSTITUTE A MAJORITY OF THE BOARD OF DIRECTORS. THE CORPORATION'S PRESIDENT SHALL SERVE AS AN EX OFFICIO VOTING AT-LARGE DIRECTOR. ADDITIONAL AT-LARGE DIRECTORS SHALL BE NOMINATED BY THE AT-LARGE DIRECTORS THEN IN OFFICE AND ELECTED BY THE BOARD OF DIRECTORS. UPON THE NOMINATION OF AN AT-LARGE DIRECTOR, THE THEN EXISTING BOARD OF DIRECTORS SHALL TAKE IMMEDIATE ACTION TO VOTE FOR THE ELECTION OF THE NOMINATED AT-LARGE DIRECTORS AND IF NECESSARY, NOMINATE AND SEEK ELECTION OF ANY ADDITIONAL MEMBER DIRECTORS. Part VI, Section A, Line 6 Members or Stockholders VERSITI, INC. (A 501(C)(3) ORGANIZATION) IS THE SOLE VOTING MEMBER. Part VI, Section A, Lines 7a and 7b Member or Stockholder Powers VERSITI, INC. HAS RESERVE POWERS, INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS. Part VI, Section B, Line 11b Form 990 Review MICHIGAN BLOOD UTILIZES GRANT THORNTON LLP TO COMPLETE THE IRS FORM 990 AND RELATED SCHEDULES. FOLLOWING COMPLETION, THEY ARE REVIEWED BY THE FINANCE/AUDIT COMMITTEE. THE FULL BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING. Part VI, Section B, Line 12c Conflict of Interest Policy ANNUALLY CONFLICT OF INTEREST STATEMENTS ARE COMPLETED BY ALL BOARD OF DIRECTORS AND KEY MEMBERS OF THE MANAGEMENT TEAM. RESPONSEs ARE COMPILED BY VERSITI'S LEGAL SERVICES TEAM TO DETERMINE IF ANY CONFLICTS EXIST. IDENTIFIED CONFLICTS ARE ADDRESSED IN ACCORDANCE WITH THE POLICy. Part VI, Section B, Lines 15a and 15B Compensation Process THE COMPENSATION COMMITTEE OF THE VERSITI BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR VERSITI AND THE RELATED ENTITIES THAT IT SUPPORTS, INCLUDING MICHIGAN BLOOD. OTHER THAN THE VERSITI PRESIDENT & CHIEF EXECUTIVE OFFICER, THE COMPENSATION COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT AND IS COMPRISED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI OR MICHIGAN BLOOD COMPENSATION ARRANGEMENTS. THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE VERSITI COMPENSATION COMMITTEE REVIEWS MICHIGAN BLOOD EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE COMPENSATION COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. THE COMPENSATION COMMITTEE ASSESSES THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS AFTER IT OBTAINS AND REVIEWS APPROPRIATE DATA FOR COMPARABILITY FROM THE HUMAN RESOURCE DEPARTMENT AND AN INDEPENDENT COMPENSATION CONSULTANT. THE COMPENSATION COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE COMPENSATION COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. VERSITI AND MICHIGAN BLOOD HAVE INCENTIVE PROGRAMS FOR THE CHIEF EXECUTIVE OFFICER AND OTHER CORPORATE OFFICERS DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE COMPENSATION COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE/COMPENSATION COMMITTEE EVALUATES THE VERSITI/MICHIGAN BLOOD CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -OTHER CORPORATE OFFICERS - EACH YEAR, THE VERSITI/MICHIGAN BLOOD CEO REVIEWS THE PERFORMANCE AND THE ACHIEVEMENT OF INDIVIDUAL GOALS AND OBJECTIVES OFEACH VERSITI/MICHIGAN BLOOD CORPORATE OFFICER. THE VERSITI/MICHIGAN BLOOD CEO PRESENTS HIS/HER RECOMMENDATIONS TO THE COMPENSATION COMMITTEE, WHICH REVIEWS AND APPROVES RECOMMENDED COMPENSATION RANGES, AND APPROVES FINAL SALARY AND INCENTIVE PAYMENTS. CORPORATE OFFICERS ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET Part VI, Section C, Line 19 Organization's Documents Open to the Public MICHIGAN BLOOD MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. Part VII Average Hours The hours listed on form 990, part vii are representative of an average for the officers and executive team. each individual person's weekly tally may be greater or lesser per week based on their individual roles and responsibilities within the filing organization and related parties. FORM 990 PART IX LINE 11G DESCRIPTION:OUTSIDE LABRATORIES TOTAL FEES:4987303 FORM 990 PART IX LINE 11G DESCRIPTION:PURCHASED SERVICES TOTAL FEES:357928 FORM 990 PART IX LINE 11G DESCRIPTION:SHIPPING AND TRANSIT TOTAL FEES:346749 FORM 990 PART IX LINE 11G DESCRIPTION:PRINTING COSTS TOTAL FEES:115752 FORM 990 PART IX LINE 11G DESCRIPTION:POSTAGE TOTAL FEES:71807 FORM 990 PART IX LINE 11G DESCRIPTION:LAUNDRY TOTAL FEES:19636 FORM 990 PART IX LINE 11G DESCRIPTION:RECORD TOTAL FEES:8531 BLOODCENTER OF WISCONSIN INC 638 NORTH 18TH MILWAUKEE WI 532332121 390807235 BLOOD WI 501(C)(3) 07 VERSITI false BLOODCENTER RESEARCH FOUNDATION INC PO BOX 2178 638 NORTH 18TH MILWAUKEE WI 53201 391372542 SUPPORTING WI 501(C)(3) 12B VERSITI false VERSITI INC PO BOX 2178 638 NORTH 18TH MILWAUKEE WI 53201 454675354 SUPPORTING WI 501(C)(3) 12B NA false AURORA AREA BLOOD BANK DBA HEARTLAND 1200 N HIGHLAND AVENUE AURORA IL 60506 362179768 BLOOD IL 501(C)(3) 10 VERSITI false CENTRAL INDIANA REGIONAL BLOOD CENTER 3450 NORTH MERIDIAN STREET INDIANAPOLIS IN 46208 350991629 BLOOD IN 501(C)(3) 10 VERSITI false false false true false false false false false false false false true true false true true true false false